Table Individual patient information

Patient number/age (y)/sex/DDDiagnosisOther signsGluten sensitivityGanglioside antibodies^/ELISADRB1HLA DQB1DRB
DD = disease duration (years); ADCA = autosomal dominant cerebellar ataxia; MSA = multiple system atrophy; IA = idiopathic ataxia; SS = slowed saccades; B = bulbar; A = autonomic; UMN = upper motor neuron; S = loss of vibratory sensation; M = myoclonus; C = cognitive impairment; EPS = extrapyramidal signs or symptoms; AGA = antigliadin antibodies; ARA = antireticulin antibodies; TTG = tissue transglutaminase antibodies; − = none detected; ? = unknown; ^ = degree of agglutination.
1/51/M/6ADCAUMN, S, AAGA3/−0101, 13020501, 06043*0301
2/63/F/9SCA8EPSAGA, ARA, TTG−/−0401, 04040301, 03024*01
3/60/F/2SCA2UMNAGA1/−1501, 00000601, 0000?
4/37/F/14SCA2B, SS, SAGA1/GM2 IgG0301, 04010201, 03053*02, 4*01
5/65/F/6SCA2B, SAGA1/GD1a IgA, GM2, IgA0701, 15010201, 05014*01, 5*01
6/71/M/3MSAB, AAGA1/GM2 IgG0101, 15010501, 06015*01
7/62/M/7MSAB, UMN, AAGA1/−0410, 15010401, 06024*01, 5*0101
8/50/M/20IAAGA−/−1302, 15010601, 06013*0301, 5*01
9/49/M/4MSAB, UMN, S, AAGA1/−1101, 15010301, 06023*0202, 5*0101
10/43/F/4ADCA?TTG1/−0101, 13010501, 06033*01
11/41/F/23ADCAB, MAGA2/GM2 IgG0101, 13010501, 06013*0301
12/68/F/2IAUMN, S−/−0801, 13020401, 06013*0301
13/55/F/9IAUMN2.5/GD1b IgG0701, 10010201, 00004*01
14/62/M/32IAS−/−0404, 11010301, 03023*0202, 4*01
15/27/F/5IAUMN, S−/−0404, 07010201, 04014*01
16/50/F/5SCA1UMN, S3/GD1b IgG, GM2 IgG, GD1b IgA1001, 11010301, 05013*02
17/27/M/17ADCA?−/−0301, 11010201, 03013*01, 3*02
18/61/M/7SCA61/−1401, 15010501, 06013*02, 5*01
19/29/F/9FAS−/−0301, 11010201, 03013*01, 3*02
20/74/F/12IAC, EPS, UMN2/GM2 IgG, GD1b IgA0401, 13010301, 06033*01, 4*01
21/31/F/5SCA51.5/GM2 IgG0401, 16010301, 05014*01, 5*02
22/62/F/4IAS−/−0101, 07010201, 05014*01